Predictive Biosciences Starts Prospective Studies for Bladder Cancer Assay
November 06, 2009
Predictive Biosciences Starts Prospective Studies for Bladder Cancer Assay
Following a successful pilot study, the company has started two prospective studies to compare how its assay performs against cystoscopy and whether it can more accurately diagnose patients who don't have bladder cancer.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- USC, U of Miami Researchers Develop Nine-Protein Panel for Predicting Bladder Cancer Progression
January 18, 2013 / ProteoMonitor - Oligo-Based Protein Capture Tools Allow Simultaneous Reporting of Genetic, Proteomic Biomarker Data
October 21, 2011 / ProteoMonitor - Adarza Aims to Launch Biomarker Detection Platform Next Year; Adds Former Roche CEO to Board
June 3, 2011 / ProteoMonitor - Proteomics Firms Net More than $8.75M in IRS Funds; Bulk of Awards Aimed at Diagnostics Work
November 5, 2010 / ProteoMonitor - Predictive Biosciences Raises $25M in Series C Funding Round
June 18, 2010 / ProteoMonitor